Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. The post will be primarily based at Guy’s Campus. The successful candidate will work closely with Professor James Arnold (https://www.linkedin.com/in/james-arnold-1a0497263/ ) to support and further develop
-
& Engineering Sci. Department: Informatics. Contact details:Martin Albrecht. martin.albrecht@kcl.ac.uk Location: Strand Campus. Category: Research. About us The Department of Informatics is looking to appoint a
-
London’s School of Biomedical Engineering & Imaging Sciences (BMEIS) and the Royal Brompton Hospital’s Imaging Department in Chelsea. The School of BMEIS (https://www.kcl.ac.uk/bmeis ) is committed
-
interview for this position. For further information about the Department of Informatics at King's, please visit https://www.kcl.ac.uk/informatics About the role Key responsibilities include: Contributing
-
particular for disorders affecting the retina, including inherited retinal degeneration (https://www.kcl.ac.uk/research/ocular-cell-and-gene-therapy-group). We are currently working up to conducting a first-in
-
such as: Systems security, Security engineering, Security testing, Computer forensics, AI for security and privacy, Security and privacy of AI. Our department addresses computer science challenges from a
-
members and 110 PhD students, and offers an exceptional multidisciplinary environment for cutting-edge cardiovascular and metabolic research. Learn more about our school (https://www.kcl.ac.uk/scms ) Our
-
Symmetry Breaking , Flavor Physics , Higgs physics , LHC , Particle Theory , Phenomenology , Quantum Field Theory , Theoretical Particle Physics Cosmology and Astroparticle Physics / Theoretical Physics
-
community?’, and ‘How have you contributed to broader society?’ See here for more information about these questions: https://royalsociety.org/topics-policy/projects/research-culture/tools-for-support/resume
-
. This role will oversee a Phase 2/3 multi-arm, multi-stage (MAMS) trial evaluating the safety and efficacy of repurposed biosimilars and biologics in adults with epidermolysis bullosa (EB). https